{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:20:47Z","timestamp":1790299247475,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Ministry of Science, ICT & Future Planning, Republic of Korea","award":["2017R1A2B4003120"],"award-info":[{"award-number":["2017R1A2B4003120"]}]},{"name":"Samsung Biomedical Research Institute","award":["OTC1190671"],"award-info":[{"award-number":["OTC1190671"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.sleep.2020.02.027","type":"journal-article","created":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T11:38:38Z","timestamp":1583581118000},"page":"81-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Patient characteristics predicting responses to intravenous ferric carboxymaltose treatment of restless legs syndrome"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7152-0754","authenticated-orcid":false,"given":"Hea Ree","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Jung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1233-959X","authenticated-orcid":false,"given":"Eun Yeon","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5123-629X","authenticated-orcid":false,"given":"Richard P.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleep.2020.02.027_bib1","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.sleep.2014.03.025","article-title":"Restless legs syndrome\/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance","volume":"15","author":"Allen","year":"2014","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2020.02.027_bib2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/00004691-200103000-00004","article-title":"Restless legs syndrome: a review of clinical and pathophysiologic features","volume":"18","author":"Allen","year":"2001","journal-title":"J\u00a0Clin Neurophysiol"},{"key":"10.1016\/j.sleep.2020.02.027_bib3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.0954-6820.1953.tb07042.x","article-title":"Therapy in restless legs","volume":"145","author":"Nordlander","year":"1953","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.sleep.2020.02.027_bib4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000008138","article-title":"A\u00a0randomized, double-blind placebo-controlled trial of iron in restless legs syndrome","volume":"43","author":"Davis","year":"2000","journal-title":"Eur Neurol"},{"key":"10.1016\/j.sleep.2020.02.027_bib5","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.sleep.2008.11.003","article-title":"Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: a randomized, double-blind, placebo-controlled study","volume":"10","author":"Wang","year":"2009","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2020.02.027_bib6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.sleep.2004.03.002","article-title":"The treatment of restless legs syndrome with intravenous iron dextran","volume":"5","author":"Earley","year":"2004","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2020.02.027_bib7","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/mds.22562","article-title":"A\u00a0randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome","volume":"24","author":"Grote","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2020.02.027_bib8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.sleep.2007.12.006","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome","volume":"10","author":"Earley","year":"2009","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2020.02.027_bib9","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.sleep.2011.06.009","article-title":"Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial","volume":"12","author":"Allen","year":"2011","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2020.02.027_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.sleep.2016.06.021","article-title":"Clinical efficacy of ferric carboxymaltose treatment in patients with restless legs syndrome","volume":"25","author":"Cho","year":"2016","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2020.02.027_bib11","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.bjhh.2015.08.012","article-title":"Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia","volume":"37","author":"Friedrisch","year":"2015","journal-title":"Rev Bras Hematol Hemoter"},{"key":"10.1016\/j.sleep.2020.02.027_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.sleep.2017.11.1134","article-title":"Efficacy of ferric carboxymaltose (FCM) 500 mg dose for the treatment of Restless Legs Syndrome","volume":"42","author":"Cho","year":"2018","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2020.02.027_bib13","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/mds.27040","article-title":"Ferric carboxymaltose in patients with restless legs syndrome and nonanemic iron deficiency: a randomized trial","volume":"32","author":"Trenkwalder","year":"2017","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2020.02.027_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.sleep.2017.11.1126","article-title":"Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome\/Willis-Ekbom disease in adults and children: an IRLSSG task force report","volume":"41","author":"Allen","year":"2018","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2020.02.027_bib15","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.sleep.2012.02.011","article-title":"Investigating the response to intravenous iron in restless legs syndrome: an observational study","volume":"13","author":"Hornyak","year":"2012","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2020.02.027_bib16","first-page":"92","article-title":"Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries","volume":"75","author":"Trenkwalder","year":"2004","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.sleep.2020.02.027_bib17","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.sleep.2014.08.012","article-title":"Response to intravenous iron in patients with iron deficiency anemia (IDA) and restless leg syndrome (Willis-Ekbom disease)","volume":"15","author":"Mehmood","year":"2014","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2020.02.027_bib18","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/gut.10.3.226","article-title":"Role of gastric secretion in iron absorption","volume":"10","author":"Jacobs","year":"1969","journal-title":"Gut"},{"key":"10.1016\/j.sleep.2020.02.027_bib19","doi-asserted-by":"crossref","first-page":"6114","DOI":"10.3748\/wjg.v18.i42.6114","article-title":"Anemia after gastrectomy for early gastric cancer: long-term follow-up observational study","volume":"18","author":"Lim","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.sleep.2020.02.027_bib20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1600-0404.1966.tb05986.x","article-title":"Restless legs syndrome after partial gastrectomy","volume":"42","author":"Ekbom","year":"1966","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.sleep.2020.02.027_bib21","doi-asserted-by":"crossref","first-page":"245358","DOI":"10.1155\/2014\/245358","article-title":"Restless leg syndrome and sleep quality in lumbar radiculopathy patients","volume":"2014","author":"Kocabicak","year":"2014","journal-title":"Behav Neurol"},{"key":"10.1016\/j.sleep.2020.02.027_bib22","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/ene.12286","article-title":"Comparison of the efficacies of oral iron and pramipexole for the treatment of restless legs syndrome patients with low serum ferritin","volume":"21","author":"Lee","year":"2014","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.sleep.2020.02.027_bib23","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/ageing\/23.3.200","article-title":"Iron status and restless legs syndrome in the elderly","volume":"23","author":"O'Keeffe","year":"1994","journal-title":"Age Ageing"},{"key":"10.1016\/j.sleep.2020.02.027_bib24","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1212\/WNL.54.8.1698","article-title":"Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome","volume":"54","author":"Earley","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2020.02.027_bib25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2869.2004.00403.x","article-title":"CSF iron, ferritin and transferrin levels in restless legs syndrome","volume":"14","author":"Mizuno","year":"2005","journal-title":"J\u00a0Sleep Res"},{"key":"10.1016\/j.sleep.2020.02.027_bib26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.sleep.2016.07.028","article-title":"Iron and restless legs syndrome: treatment, genetics and pathophysiology","volume":"31","author":"Connor","year":"2017","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2020.02.027_bib27","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.sleep.2009.12.002","article-title":"Intravenous iron dextran for severe refractory restless legs syndrome","volume":"11","author":"Ondo","year":"2010","journal-title":"Sleep Med"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945720301076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945720301076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:27:59Z","timestamp":1761406079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945720301076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":27,"alternative-id":["S1389945720301076"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2020.02.027","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient characteristics predicting responses to intravenous ferric carboxymaltose treatment of restless legs syndrome","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2020.02.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}